BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36299464)

  • 21. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease.
    Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD
    J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease.
    Ding H; Li LX; Harris PC; Yang J; Li X
    Nat Commun; 2021 Jul; 12(1):4548. PubMed ID: 34315885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.
    Woo YM; Bae JB; Oh YH; Lee YG; Lee MJ; Park EY; Choi JK; Lee S; Shin Y; Lyu J; Jung HY; Lee YS; Hwang YH; Kim YJ; Park JH
    Hum Genet; 2014 Mar; 133(3):281-97. PubMed ID: 24129831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease.
    Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R
    Clin Lab; 2017 Jul; 63(7):1261-1267. PubMed ID: 28792715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nedd9 restrains renal cystogenesis in Pkd1-/- mice.
    Nikonova AS; Plotnikova OV; Serzhanova V; Efimov A; Bogush I; Cai KQ; Hensley HH; Egleston BL; Klein-Szanto A; Seeger-Nukpezah T; Golemis EA
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12859-64. PubMed ID: 25139996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease.
    Stekrova J; Reiterova J; Svobodova S; Kebrdlova V; Lnenicka P; Merta M; Viklicky O; Kohoutova M
    BMC Med Genet; 2009 Aug; 10():78. PubMed ID: 19686598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants.
    Raj S; Singh RG; Das P
    Mutat Res; 2020; 821():111718. PubMed ID: 32823016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
    Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
    Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes.
    Magistroni R; Mangolini A; Guzzo S; Testa F; Rapanà MR; Mignani R; Russo G; di Virgilio F; Aguiari G
    BMC Nephrol; 2019 Sep; 20(1):355. PubMed ID: 31514750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
    Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C
    Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A missense mutation in PKD1 attenuates the severity of renal disease.
    Pei Y; Lan Z; Wang K; Garcia-Gonzalez M; He N; Dicks E; Parfrey P; Germino G; Watnick T
    Kidney Int; 2012 Feb; 81(4):412-7. PubMed ID: 22031115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.
    Hopp K; Ward CJ; Hommerding CJ; Nasr SH; Tuan HF; Gainullin VG; Rossetti S; Torres VE; Harris PC
    J Clin Invest; 2012 Nov; 122(11):4257-73. PubMed ID: 23064367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.
    Chebib FT; Jung Y; Heyer CM; Irazabal MV; Hogan MC; Harris PC; Torres VE; El-Zoghby ZM
    Nephrol Dial Transplant; 2016 Jun; 31(6):952-60. PubMed ID: 26932689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease.
    Shigemori K; Higashihara E; Itoh M; Yoshida H; Yamamoto K; Nutahara K; Shiokawa Y; Kaname S; Tambo M; Yamaguchi T; Taguchi S; Yoshioka T; Yokoyama K; Fukuhara H
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105943. PubMed ID: 34175641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autosomal dominant polycystic kidney disease (ADPKD) in Tunisia: From molecular genetics to the development of prognostic tools.
    Abdelwahed M; Hilbert P; Ahmed A; Dey M; Bouomrani S; Kamoun H; Ammar-Keskes L; Belguith N
    Gene; 2022 Apr; 817():146174. PubMed ID: 35031424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease.
    Liu D; Wang CJ; Judge DP; Halushka MK; Ni J; Habashi JP; Moslehi J; Bedja D; Gabrielson KL; Xu H; Qian F; Huso D; Dietz HC; Germino GG; Watnick T
    J Am Soc Nephrol; 2014 Jan; 25(1):81-91. PubMed ID: 24071006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pannexin-1 mediates fluid shear stress-sensitive purinergic signaling and cyst growth in polycystic kidney disease.
    Verschuren EHJ; Rigalli JP; Castenmiller C; Rohrbach MU; Bindels RJM; Peters DJM; Arjona FJ; Hoenderop JGJ
    FASEB J; 2020 May; 34(5):6382-6398. PubMed ID: 32159259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis.
    Higashihara E; Horie S; Kinoshita M; Harris PC; Okegawa T; Tanbo M; Hara H; Yamaguchi T; Shigemori K; Kawano H; Miyazaki I; Kaname S; Nutahara K
    Clin Exp Nephrol; 2018 Apr; 22(2):395-404. PubMed ID: 28983800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of kidney disease varies between families with defects in the polycystic kidney disease type 1 gene in eastern Finland.
    Lumiaho A; Ikäheimo R; Pihlajamäki J; Miettinen R; Niemitukia L; Vanninen R; Lampainen E; Laakso M
    Scand J Urol Nephrol; 2003; 37(4):352-8. PubMed ID: 12944197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.